260 related articles for article (PubMed ID: 17036955)
1. [For prevention of cardiovascular diseases: statins in old age?].
MMW Fortschr Med; 2006 Sep; 148(38):16. PubMed ID: 17036955
[No Abstract] [Full Text] [Related]
2. [Disordered lipid metabolism--current diagnostics].
Schwandt P
MMW Fortschr Med; 2003 Mar; 145(13):26-7. PubMed ID: 15101528
[No Abstract] [Full Text] [Related]
3. [Total cardiovascular risk. When is a medication prophylaxis meaningful].
Einecke D
MMW Fortschr Med; 2003 Oct; 145(44):6-8. PubMed ID: 14655495
[No Abstract] [Full Text] [Related]
4. [Lowering cholesterol in the elderly--yes, no, or maybe?].
Gogol M
MMW Fortschr Med; 2006 Mar; 148(12):40-3. PubMed ID: 16626005
[TBL] [Abstract][Full Text] [Related]
5. [Statins in practice of the vascular surgeon and cardiologist].
Pokrovskiĭ AV; Suntsov DS
Angiol Sosud Khir; 2009; 15(2):123-7. PubMed ID: 19806952
[TBL] [Abstract][Full Text] [Related]
6. Primary and secondary prevention of cardiovascular disease in the elderly.
García-Palmieri MR
Bol Asoc Med P R; 2000; 92(1-3):3-8. PubMed ID: 10846280
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).
LaRosa JC; Grundy SM; Kastelein JJ; Kostis JB; Greten H;
Am J Cardiol; 2007 Sep; 100(5):747-52. PubMed ID: 17719314
[TBL] [Abstract][Full Text] [Related]
8. Trials and tribulations.
Packard CJ
Int J Clin Pract Suppl; 2002 Oct; (132):3-10. PubMed ID: 12425357
[No Abstract] [Full Text] [Related]
9. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
[TBL] [Abstract][Full Text] [Related]
10. Clash of the statins? A trial pitting two popular statins against each other helps answer a far more important question: how low should cholesterol go?
Harv Heart Lett; 2004 Feb; 14(6):5. PubMed ID: 14980886
[No Abstract] [Full Text] [Related]
11. Statins and the stroke-cholesterol paradox.
Van de Wiel A; Caillard CA
Neth J Med; 2002 Mar; 60(1):4-9. PubMed ID: 12074043
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
Robins SJ; Collins D; Nelson JJ; Bloomfield HE; Asztalos BF
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1172-8. PubMed ID: 18356553
[TBL] [Abstract][Full Text] [Related]
13. [Policy paper on primary prevention of cardiovascular diseases. Current draft of 3/25/2003 issued by the Executive Committee of the German Society of Cardiology, Heart and Circulation Research. Edited by the Prevention Project Group on behalf of the Executive Committee].
Gohlke H; Kübler W; Mathes P; Meinertz T; Schuler G; Gysan DB; Sauer G;
Z Kardiol; 2003 Jun; 92(6):522-3. PubMed ID: 12905981
[No Abstract] [Full Text] [Related]
14. [Hypercholesterolemia, cardiovascular risk, and hypocholesteremic treatment in the elderly].
Cicconetti P; Ciotti V; Tafaro L; Riolo N; Marigliano V
Recenti Prog Med; 2002 Apr; 93(4):264-72. PubMed ID: 11989134
[TBL] [Abstract][Full Text] [Related]
15. Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study.
Fonseca FA; Izar MC
Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1041-56. PubMed ID: 19764857
[TBL] [Abstract][Full Text] [Related]
16. [Meta-analysis finds cardioprotective effects: renaissance of hormone replacement therapy? Interview by Katharina Arnheim].
Kuhl H
MMW Fortschr Med; 2006 Jun; 148(26):14. PubMed ID: 16878361
[No Abstract] [Full Text] [Related]
17. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
Hennekens CH; Schneider WR
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
[TBL] [Abstract][Full Text] [Related]
18. [Lowering of LDL cholesterol prevents cardiovascular diseases. "Normal values" are too high--treatment time is a crucial factor].
Rudling M
Lakartidningen; 2006 Oct 25-31; 103(43):3278-82. PubMed ID: 17117659
[No Abstract] [Full Text] [Related]
19. [Primary and secondary prevention of arteriosclerosis. Risk stratification of hypertension].
Gysan DB
Z Kardiol; 2002 Oct; 91(10):777-85. PubMed ID: 12395218
[TBL] [Abstract][Full Text] [Related]
20. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.
Kones R
Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):309-15. PubMed ID: 19460829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
